메뉴 건너뛰기




Volumn 56, Issue 5, 2016, Pages 1121-1128

Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN S;

EID: 84962248860     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13548     Document Type: Article
Times cited : (22)

References (16)
  • 1
    • 5044239523 scopus 로고    scopus 로고
    • Sickle-cell disease
    • Stuart MJ, Nagel RL., Sickle-cell disease. Lancet 2004; 364: 1343-60.
    • (2004) Lancet , vol.364 , pp. 1343-1360
    • Stuart, M.J.1    Nagel, R.L.2
  • 2
    • 84862778943 scopus 로고    scopus 로고
    • Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities
    • Aygun B, Wruck LM, Schultz WH, et al., Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities. Am J Hematol 2012; 87: 428-30.
    • (2012) Am J Hematol , vol.87 , pp. 428-430
    • Aygun, B.1    Wruck, L.M.2    Schultz, W.H.3
  • 3
    • 0031965089 scopus 로고    scopus 로고
    • Cerebrovascular accidents in sickle cell disease: Rates and risk factors
    • Ohene-Frempong K, Weiner SJ, Sleeper LA, et al., Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288-94.
    • (1998) Blood , vol.91 , pp. 288-294
    • Ohene-Frempong, K.1    Weiner, S.J.2    Sleeper, L.A.3
  • 4
    • 0026724041 scopus 로고
    • Transcranial Doppler correlation with cerebral angiography in sickle cell disease
    • Adams RJ, Nichols FT, Figueroa R, et al., Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 1992; 23: 1073-7.
    • (1992) Stroke , vol.23 , pp. 1073-1077
    • Adams, R.J.1    Nichols, F.T.2    Figueroa, R.3
  • 6
    • 0036220398 scopus 로고    scopus 로고
    • Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke
    • Scothorn DJ, Price C, Schwartz D, et al., Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002; 140: 348-54.
    • (2002) J Pediatr , vol.140 , pp. 348-354
    • Scothorn, D.J.1    Price, C.2    Schwartz, D.3
  • 7
    • 33746594094 scopus 로고    scopus 로고
    • Stroke prevention trial in sickle cell anemia (STOP): Extended follow-up and final results
    • Lee MT, Piomelli S, Granger S, et al., Stroke prevention trial in sickle cell anemia (STOP): extended follow-up and final results. Blood 2006; 108: 847-52.
    • (2006) Blood , vol.108 , pp. 847-852
    • Lee, M.T.1    Piomelli, S.2    Granger, S.3
  • 8
    • 58149269437 scopus 로고    scopus 로고
    • Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia
    • Bader-Meunier B, Verlhac S, Elmaleh-Berges M, et al., Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia. Haematologica 2009; 94: 123-6.
    • (2009) Haematologica , vol.94 , pp. 123-126
    • Bader-Meunier, B.1    Verlhac, S.2    Elmaleh-Berges, M.3
  • 9
    • 84923172219 scopus 로고    scopus 로고
    • A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients
    • Kuo KH, Ward R, Kaya B, et al., A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients. Br J Haematol 2015; 170: 425-8.
    • (2015) Br J Haematol , vol.170 , pp. 425-428
    • Kuo, K.H.1    Ward, R.2    Kaya, B.3
  • 10
    • 0026552537 scopus 로고
    • A modified transfusion program for prevention of stroke in sickle cell disease
    • Cohen AR, Martin MB, Silber JH, et al., A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992; 79: 1657-61.
    • (1992) Blood , vol.79 , pp. 1657-1661
    • Cohen, A.R.1    Martin, M.B.2    Silber, J.H.3
  • 11
    • 84923020660 scopus 로고    scopus 로고
    • Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease
    • 55:357-63
    • Michot JM, Driss F, Guitton C, et al., Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease. Transfusion 2015;55:357-63.
    • (2015) Transfusion
    • Michot, J.M.1    Driss, F.2    Guitton, C.3
  • 12
    • 84870988240 scopus 로고    scopus 로고
    • Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions
    • Wahl SK, Garcia A, Hagar W, et al., Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Transfusion 2012; 52: 2671-6.
    • (2012) Transfusion , vol.52 , pp. 2671-2676
    • Wahl, S.K.1    Garcia, A.2    Hagar, W.3
  • 13
    • 0027958085 scopus 로고
    • Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease
    • Kim HC, Dugan NP, Silber JH, et al., Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994; 83: 1136-42.
    • (1994) Blood , vol.83 , pp. 1136-1142
    • Kim, H.C.1    Dugan, N.P.2    Silber, J.H.3
  • 14
    • 73949153192 scopus 로고    scopus 로고
    • Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury
    • Adamkiewicz TV, Abboud MR, Paley C, et al., Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood 2009; 114: 4632-8.
    • (2009) Blood , vol.114 , pp. 4632-4638
    • Adamkiewicz, T.V.1    Abboud, M.R.2    Paley, C.3
  • 16
    • 84355166625 scopus 로고    scopus 로고
    • Challenges of adherence and persistence with iron chelation therapy
    • Porter JB, Evangeli M, El-Beshlawy A., Challenges of adherence and persistence with iron chelation therapy. Int J Hematol 2011; 94: 453-60.
    • (2011) Int J Hematol , vol.94 , pp. 453-460
    • Porter, J.B.1    Evangeli, M.2    El-Beshlawy, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.